|
Novo Nordisk's operating profit increased by 15% in the first quarter of 2010
|
27 April 2010 |
|
Superior efficacy of Victoza® (liraglutide) compared to Januvia® (sitagliptin)
|
23 April 2010 |
|
Novo Nordisk launches international survey into the psychosocial effects of living with haemophilia
|
16 April 2010 |
|
Novo Nordisk Introduces New Industry Resource for Information on Diabetes and Chronic Disease
|
31 March 2010 |
|
Novo Nordisk receives FDA approval for Norditropin® FlexPro® for growth hormone treatment
|
04 March 2010 |
|
Novo Nordisk receives approval for Victoza® in Japan
|
25 January 2010 |
|
Novo Nordisk starts phase 1 trial with long-acting oral GLP-1 analogue
|
14 January 2010 |
|
Novo Nordisk starts phase 1 trial with oral insulin analogue
|
08 December 2009 |
|
Novo Nordisk increased operating profit by 30% in the first nine months of 2009
|
30 October 2009 |
|
The 4-T study of intensified insulin regimens shows excellent three-year glucose control
|
23 October 2009 |